OTCM
BDMSF
Market cap11bUSD
, Last price
USD
Name
Bangkok Dusit Medical Services PCL
Chart & Performance
Profile
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals. The company owns and manages 6 hospital groups, including Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. It operates holistic clinical wellness. In addition, the company operates hotels and restaurant; sells health and cosmetic products; provides accounting, health insurance, laboratory services, investment, information technology, training, skin and aesthetics telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, and property management services, as well as asset management services; and manufactures and distributes medicine and pharmaceutical products. Further, it is involved in the e-commerce and real estate business. The company operates 47 hospitals in Thailand and Cambodia. Bangkok Dusit Medical Services Public Company Limited was incorporated in 1969 and is based in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 107,867,221 6.96% | 100,852,576 9.70% | 91,933,635 23.48% | |||||||
Cost of revenue | 88,898,903 | 83,218,072 | 75,983,947 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 18,968,318 | 17,634,505 | 15,949,687 | |||||||
NOPBT Margin | 17.58% | 17.49% | 17.35% | |||||||
Operating Taxes | 3,792,162 | 3,754,547 | 3,227,151 | |||||||
Tax Rate | 19.99% | 21.29% | 20.23% | |||||||
NOPAT | 15,176,155 | 13,879,957 | 12,722,537 | |||||||
Net income | 15,987,010 11.21% | 14,375,267 14.03% | 12,606,203 58.85% | |||||||
Dividends | (11,119,075) | (10,342,943) | (7,943,365) | |||||||
Dividend yield | 2.86% | 2.35% | 1.72% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 4,818,173 | 2,817,089 | 6,412,216 | |||||||
Long-term debt | 21,398,291 | 22,952,261 | 24,745,875 | |||||||
Deferred revenue | 464,295 | 516,209 | 486,095 | |||||||
Other long-term liabilities | 7,536,380 | 6,292,828 | 5,625,600 | |||||||
Net debt | 15,037,049 | 14,166,223 | 14,205,836 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 22,957,778 | 20,778,387 | 20,266,379 | |||||||
CAPEX | (10,729,692) | (8,306,626) | (5,072,441) | |||||||
Cash from investing activities | (11,384,682) | (7,754,168) | (5,901,375) | |||||||
Cash from financing activities | (11,969,810) | (17,897,400) | (12,630,646) | |||||||
FCF | 8,468,574 | 8,068,121 | 3,745,277 | |||||||
Balance | ||||||||||
Cash | 8,715,503 | 9,494,870 | 14,987,578 | |||||||
Long term investments | 2,463,912 | 2,108,256 | 1,964,677 | |||||||
Excess cash | 5,786,054 | 6,560,497 | 12,355,573 | |||||||
Stockholders' equity | 61,957,848 | 68,530,556 | 53,372,718 | |||||||
Invested Capital | 124,499,034 | 117,255,037 | 109,591,220 | |||||||
ROIC | 12.56% | 12.24% | 12.07% | |||||||
ROCE | 14.12% | 13.78% | 12.67% | |||||||
EV | ||||||||||
Common stock shares outstanding | 15,892,002 | 15,892,002 | 15,892,002 | |||||||
Price | 24.50 -11.71% | 27.75 -4.31% | 29.00 26.09% | |||||||
Market cap | 389,354,046 -11.71% | 441,003,053 -4.31% | 460,868,055 26.09% | |||||||
EV | 408,281,025 | 458,799,487 | 478,907,426 | |||||||
EBITDA | 25,100,046 | 23,482,550 | 21,899,316 | |||||||
EV/EBITDA | 16.27 | 19.54 | 21.87 | |||||||
Interest | 433,386 | 546,592 | 632,065 | |||||||
Interest/NOPBT | 2.28% | 3.10% | 3.96% |